ALB and Nephropathy: Early detection is critical to prevent renal function decline and improve outcomes, but conventional biomarkers (e.g., urinary albumin-to-creatinine ratio [UACR] and estimated glomerular filtration rate [eGFR]) have limited sensitivity for early-stage kidney damage.